<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-B33JUDBL/db15--4ccea5423afa4e40-c1caeb2c9bf-3/PDF"><dcterms:extent>24254 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-B33JUDBL/2c3d7e2b-b09e-4ba9-b5dc-1c2159190cc0/TEXT"><dcterms:extent>0 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-B33JUDBL/bff85947-e27f-45ac-b7be-a0f57385c33f/WEB"><dcterms:extent>0 KB</dcterms:extent></edm:WebResource><edm:ProvidedCHO rdf:about="URN:NBN:SI:DOC-B33JUDBL"><dcterms:issued>2020</dcterms:issued><dc:contributor>Božič, Borut</dc:contributor><dc:contributor>Čučnik, Saša</dc:contributor><dc:creator>Ogrič, Manca</dc:creator><dc:contributor>Praprotnik, Sonja</dc:contributor><dc:contributor>Štrukelj, Borut</dc:contributor><dc:contributor>Tomšič, Matija</dc:contributor><dc:format xml:lang="sl">XII, 173 str.</dc:format><dc:identifier>COBISSID:46272515</dc:identifier><dc:identifier>PID:https://repozitorij.uni-lj.si/IzpisGradiva.php?id=137113</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-B33JUDBL</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">M. Ogrič</dc:publisher><dc:source xml:lang="sl">visokošolska dela</dc:source><dc:subject xml:lang="sl">adalimumab</dc:subject><dc:subject xml:lang="sl">avtoimunske bolezni</dc:subject><dc:subject xml:lang="sl">biološka zdravila</dc:subject><dc:subject xml:lang="en">immunogenicity</dc:subject><dc:subject xml:lang="sl">imunogenost</dc:subject><dc:subject xml:lang="sl">infliksimab</dc:subject><dc:subject xml:lang="en">infliximab</dc:subject><dc:subject xml:lang="sl">koronarne arterije</dc:subject><dc:subject xml:lang="sl">protitelesa</dc:subject><dc:subject xml:lang="sl">vnetno stimulirane humane endotelijske celice</dc:subject><dc:title xml:lang="sl">Imunogenost infliksimaba in adalimumaba ter njun vpliv na vnetno stimulirane humane endotelijske celice koronarne arterije| doktorska disertacija| Immunogenicity of infliximab and adalimumab and their influence on inflammatory stimulated human coronary artery endothelial cells|</dc:title><edm:type>TEXT</edm:type><dc:type xml:lang="sl">visokošolska dela</dc:type><dc:type xml:lang="en">theses and dissertations</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q1266946" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:DOC-B33JUDBL"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:DOC-B33JUDBL" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:DOC-B33JUDBL/db15--4ccea5423afa4e40-c1caeb2c9bf-3/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Univerza v Ljubljani, Fakulteta za farmacijo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:DOC-B33JUDBL/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:DOC-B33JUDBL" /></ore:Aggregation></rdf:RDF>